Helix Biopharma GAAP EPS of -$0.09
Source: SeekingAlpha
2025-10-29 17:49:42 ET
More on Helix BioPharma Corp.
- Seeking Alpha’s Quant Rating on Helix BioPharma Corp.
- Financial information for Helix BioPharma Corp.
Read the full article on Seeking Alpha
For further details see:
Helix Biopharma GAAP EPS of -$0.09
Helix Biopharma Corp
NASDAQ: HBPCF
HBPCF Trading
0.0% G/L:
$1.73 Last:
100 Volume:
$1.73 Open:
HBPCF Latest News
March 16, 2026 05:00:00 pm
Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
February 24, 2026 09:00:00 am
Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
February 05, 2026 04:30:00 pm
Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
HBPCF Stock Data
$104,197,388
75,324,080
0.06%
20
N/A
Biotechnology & Life Sciences
Healthcare
CA
Toronto
